Matches in Wikidata for { <http://www.wikidata.org/entity/Q58421291> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q58421291 description "artículu científicu espublizáu n'avientu de 1998" @default.
- Q58421291 description "im Dezember 1998 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58421291 description "scientific article published on 01 December 1998" @default.
- Q58421291 description "wetenschappelijk artikel" @default.
- Q58421291 description "наукова стаття, опублікована в грудні 1998" @default.
- Q58421291 name "Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients" @default.
- Q58421291 name "Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients" @default.
- Q58421291 type Item @default.
- Q58421291 label "Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients" @default.
- Q58421291 label "Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients" @default.
- Q58421291 prefLabel "Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients" @default.
- Q58421291 prefLabel "Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients" @default.
- Q58421291 P1433 Q58421291-6FAAF9E2-8024-4F4E-AFEF-7167AA84BB03 @default.
- Q58421291 P1476 Q58421291-D9504C78-BD19-4BC8-B764-3EF69EE024DB @default.
- Q58421291 P2093 Q58421291-23CE8260-8C7D-4A76-BBE3-A05CD10F55F4 @default.
- Q58421291 P2093 Q58421291-63B6C842-1C39-4798-9CF7-01926D21321D @default.
- Q58421291 P2093 Q58421291-A56850CA-9037-4CB5-9CCF-E0A8168E7983 @default.
- Q58421291 P2093 Q58421291-C4F8F159-6D37-4087-ACAC-849B154BCDE4 @default.
- Q58421291 P2093 Q58421291-D2E81D92-711F-431B-BF70-79939C374FCE @default.
- Q58421291 P304 Q58421291-B9FF61E8-48F4-4916-BD33-E60E8E302E5A @default.
- Q58421291 P31 Q58421291-25A81606-1F3A-4024-8F4E-C29CC9B6D690 @default.
- Q58421291 P407 Q58421291-93F1E8FD-D722-41DB-845B-A4FAE74A539E @default.
- Q58421291 P433 Q58421291-8447F26A-7F05-4AC1-85FC-40F421AC371A @default.
- Q58421291 P478 Q58421291-ABE35E74-EFFD-4847-9AD4-4A94CAD4AB52 @default.
- Q58421291 P50 Q58421291-E269D1DB-43DA-4876-AB60-3B8E51FED350 @default.
- Q58421291 P577 Q58421291-DE818B40-B42F-46EC-B962-3D1EF9CC7F21 @default.
- Q58421291 P698 Q58421291-1BFF9954-FC13-4D99-8A10-64CE60F54273 @default.
- Q58421291 P698 9861778 @default.
- Q58421291 P1433 Q15759787 @default.
- Q58421291 P1476 "Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients" @default.
- Q58421291 P2093 "FitzGerald GA" @default.
- Q58421291 P2093 "Merli M" @default.
- Q58421291 P2093 "Praticò D" @default.
- Q58421291 P2093 "Riggio O" @default.
- Q58421291 P2093 "Rossi E" @default.
- Q58421291 P304 "430-434" @default.
- Q58421291 P31 Q13442814 @default.
- Q58421291 P407 Q1860 @default.
- Q58421291 P433 "9" @default.
- Q58421291 P478 "46" @default.
- Q58421291 P50 Q37834358 @default.
- Q58421291 P577 "1998-12-01T00:00:00Z" @default.
- Q58421291 P698 "9861778" @default.